| abstract |
The present invention discloses a method for preparing the novel antagonists and such compounds for melanin concentrating hormone (MCH). In another embodiment, the present invention relates to pharmaceutical compositions comprising such MCHs and methods of using them in the treatment of obesity, metabolic disorders, eating disorders (overeating) and diabetes. This generally involves novel compounds having MCH receptor modulator activity, pharmaceutical compositions containing one or more such modulators, methods of preparing such modulators, and obesity, diabetes and related disorders. It discloses a method of using such modulators for treatment. |